Web
Analytics
The news is by your side.

Precision cancer therapy

Precision cancer therapy works in 3/4 of patients: study

MIAMI: A precision cancer treatment that targets rare genetic mutations that exist in about 5,000 people in the United States instead of the tumor's location in the body has shown success in three-quarters of patients, researchers said Wednesday. The medicine, called larotrectinib, is made by Loxo Oncology of Stamford, Connecticut and was granted breakthrough therapy designation by the US Food and Drug Administration in 2016. Taken orally once or twice a day, it interferes with an on-switch for cancer growth caused by…